Leveraging Australia’s unique translational ecosystem and robust manufacturing capacity, Seth Cheetham and his team are driving innovation in mRNA-based therapies.
A year to the day after the Trump administration slashed $500 million in funding from mRNA-based programs, the FDA approved ...
Personalized mRNA cancer vaccines are showing early success in clinical trials, fueling optimism in the fight against cancer.
The U.S. Food and Drug Administration has approved a new seasonal flu vaccine from Moderna that uses mRNA technology, the drugmaker announced Wednesday. Called mFLUSIVA, it is approved for adults ages ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results